Abstract
The serum insulin-like growth factor-I (IGF-I) concentration is commonly used as a screening tool for growth hormone deficiency (GHD), but there is no consensus on the cut-off limit of IGF-I standard deviation score (SDS) to perform GH stimulation tests for confirmation or exclusion of GHD. We argue that the cut-off limit is dependent on the clinical pre-test likelihood of GHD and propose a diagnostic strategy in which the cut-off limit varies between zero to -2 SDS.
| Dokumententyp: | Zeitschriftenartikel | 
|---|---|
| Fakultät: | Medizin | 
| Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit | 
| ISSN: | 1308-5727 | 
| Sprache: | Englisch | 
| Dokumenten ID: | 88132 | 
| Datum der Veröffentlichung auf Open Access LMU: | 25. Jan. 2022 09:26 | 
| Letzte Änderungen: | 25. Jan. 2022 09:26 | 
 
		 
	 
    


